about
Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalisDocking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expressionVirtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes.Virtual screening against nuclear factor κB (NF-κB) of a focus library: Identification of bioactive furocoumarin derivatives inhibiting NF-κB dependent biological functions involved in cystic fibrosis.Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines.Apoptosis of human primary osteoclasts treated with molecules targeting nuclear factor-kappaB.The loss of cellular junctions in epithelial lung cells induced by cigarette smoke is attenuated by corilaginGBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules.Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives.Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development.miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.Involvement of miRNA in erythroid differentiation.Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222.Phloridzin derivatives inhibiting pro-inflammatory cytokine expression in human cystic fibrosis IB3-1 cells.Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin.Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cellsAntibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses.Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells.Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.Phytochemical and pharmacological properties of essential oils from Cedrus species.In vitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells.Antioxidant and antiproliferative activity of Laurus nobilis L. (Lauraceae) leaves and seeds essential oils against K562 human chronic myelogenous leukaemia cells.C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.Modulators of sphingolipid metabolism reduce lung inflammation.Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function.Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproductsBergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives.New furan side tetracyclic allopsoralen derivatives: synthesis and photobiological evaluation.Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.
P50
Q21254649-AC62CE82-D0C4-4089-A6D1-0D43945E1540Q33366140-821C2BCC-8083-4D02-8CCF-6430A68A5A11Q33508859-DA6C8035-4D5B-43C4-96C9-4F70B024F065Q33729936-AB105388-4D71-49B7-8FB2-DF94C9BA5068Q33874258-78C6E82E-35F0-40D2-A1BD-1BE4B6594C17Q34611393-1CA289DA-F787-48EB-A54E-5644A4D107F4Q35162508-329E321B-225B-4C46-8AE7-ABE936ECA59EQ35228672-14187C9C-58F4-40D8-A8A0-EBD298096605Q35301892-9E55E7EE-A5BA-454B-AFED-92228E1EBBBFQ36611332-37E4BBA0-BF81-4F46-BA2D-3032747AB111Q36753123-643D2E57-DA5A-4C96-8017-7A4640EBAD0EQ37309900-9E528C94-C16B-4AE7-9570-36DD234EA8CEQ37590391-318D6501-7E1B-49B2-988D-0B188D79420EQ37921863-F10AF90F-2624-4FD6-947E-FE3054301314Q37962609-29377C00-0A39-4CE7-B34E-12D5BFACB82AQ37983889-D168F39D-EBFC-4E63-83D3-ED9CF32D6AABQ38360640-E4995333-695C-4B64-9430-ECE4950E907EQ38808735-EBBC0CC0-24BB-426C-BFB8-BE543B6F0A6EQ38849435-3197E0E2-491C-46DB-A0F4-00CCD140A3E8Q38907520-BF113269-6717-47C4-A1FE-7D950ADCEB3FQ38929902-D2341DC2-4002-4FF5-9F34-D7FBF040E3F3Q38939602-3E169741-E782-43C4-ADAD-AD1DA55DEF19Q38958442-BC137FF3-26A9-47E1-946A-F81BBC168686Q39033925-7AC97950-4BBC-40BD-B61F-9779A06B07DCQ39353313-D0A4661D-E683-4DE6-85A5-8A107014C42CQ39388051-FE606876-17A5-44BD-A5DD-1BC3A7B63468Q39410705-3412E78F-7F3B-4762-9E82-32477FAB0CBBQ39428800-DC141FD4-C3D9-4791-AC2C-22959C2E791BQ39454834-61BC70B4-8DB4-449C-AAE4-07B0B7CBA983Q39465808-895C753F-8111-41CA-9226-9C9B1C28834EQ39527379-7F552504-4D86-4522-A630-E71FC2C4F4F3Q39621248-760F0A9D-72AD-4541-A286-CFC0C54D64C1Q39795854-9C74CEE8-E955-432B-A311-DF2379E37DFAQ39814424-28C74D35-1002-4CC0-BC8A-FAB444C22AFCQ39860344-1BF25207-8E48-4125-881F-BA9A533B5568Q40049519-9C923A4C-59AB-4DFF-B177-8D4A8BE065DBQ40258814-C6A3B228-6E62-408D-BDAC-4B4519CD6DE8Q40529667-3D5CD914-AE31-4174-9AC6-62A17DE71B22Q40746113-B4B78488-AA58-49F9-AC0D-6DF1458EEB86Q42224585-203E610F-021E-4D75-875D-B75B2353F8A5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ilaria Lampronti
@ast
Ilaria Lampronti
@en
Ilaria Lampronti
@es
Ilaria Lampronti
@nl
Ilaria Lampronti
@sl
type
label
Ilaria Lampronti
@ast
Ilaria Lampronti
@en
Ilaria Lampronti
@es
Ilaria Lampronti
@nl
Ilaria Lampronti
@sl
prefLabel
Ilaria Lampronti
@ast
Ilaria Lampronti
@en
Ilaria Lampronti
@es
Ilaria Lampronti
@nl
Ilaria Lampronti
@sl
P1053
F-5522-2016
P106
P1153
6602263795
P21
P31
P3829
P496
0000-0002-1972-7766